Equities

Sigma Healthcare Ltd

Sigma Healthcare Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (AUD)1.18
  • Today's Change-0.005 / -0.42%
  • Shares traded8.83m
  • 1 Year change+51.23%
  • Beta0.2595
Data delayed at least 20 minutes, as of Jun 07 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.

  • Revenue in AUD (TTM)3.42bn
  • Net income in AUD4.51m
  • Incorporated1999
  • Employees156.00
  • Location
    Sigma Healthcare LtdLevel 6, 2125 Dandenong Road, ClaytonMELBOURNE 3168AustraliaAUS
  • Phone+61 39215-9215
  • Fax+61 39215-9188
  • Websitehttps://sigmahealthcare.com.au/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SIG:ASX since
announced
Transaction
value
CW Group Holdings LtdAnnounced11 Dec 202311 Dec 2023Announced58.78%5.45bn
Data delayed at least 20 minutes, as of Jun 07 2024 07:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Uniphar PLC4.19bn73.54m1.16bn3.26k15.722.128.740.27590.16410.16419.351.222.1312.6412.71782,667.703.764.126.497.2415.2813.611.771.870.56343.220.533810.9323.3012.48-1.6938.9845.53--
NanJing Pharmaceutical Co Ltd11.20bn123.19m1.28bn4.90k10.300.9142--0.1140.45130.451341.075.091.638.333.3310,903,610.002.222.327.448.946.046.411.361.301.132.910.635929.826.7111.35-3.0016.93-12.679.86
Selcuk Ecza Deposu Ticaret ve Sanayi AS4.59bn10.49m1.43bn6.03k136.552.0247.580.31190.35940.3594157.3624.252.3010.7310.4216,218,930.000.52553.161.418.409.389.370.22841.241.05--0.138227.1614.7048.64-64.89-10.6223.1320.11
Neuca SA4.55bn58.94m1.52bn5.19k26.333.7314.090.33334.2534.252,647.46241.932.377.477.172,307,345.003.303.5812.2713.3111.1910.331.391.430.50344.220.303234.595.178.796.588.95-3.0714.40
DocMorris AG1.64bn-199.30m1.52bn1.45k--1.70--0.926-10.077.0383.0536.600.986311.3610.50667,214.10-11.96-12.92-15.23-15.7420.9816.84-12.13-10.871.34-2.390.4448--4.13-4.2931.29---2.53--
Herbalife Ltd7.71bn208.42m1.65bn9.20k7.92--4.310.21391.371.3750.57-10.391.902.2558.67551,586.905.1411.308.6818.7076.8078.432.706.020.76672.981.760.00-2.730.688-55.74-13.679.95--
Guangxi LiuYao Group Co Ltd4.45bn186.30m1.81bn5.58k8.821.13--0.40752.462.4658.8219.121.076.991.973,807,204.004.805.0611.7312.2111.5611.854.474.401.305.260.543429.909.2312.1821.119.97-8.636.26
Sigma Healthcare Ltd3.42bn4.51m1.96bn156.00303.802.1658.220.5730.0040.0043.340.55442.6811.3710.52--0.41620.57340.6250.97629.179.520.15540.20221.861.590.1354184.52-9.16-3.46148.98-34.19-46.55-21.93
GuangYuYuan Chinese Herbal Medicn Co Ltd263.74m25.48m2.30bn1.81k90.427.15--8.740.24840.24842.573.140.47010.76611.99694,836.904.96-2.107.42-3.1671.4369.7410.56-6.001.1612.910.1569--13.56-4.53136.03-24.78-58.35--
Tibet Rhodiola Pharmaceutical Holding Co614.44m169.90m2.51bn601.0013.252.52--4.092.812.819.6514.760.60161.816.684,877,892.0016.8312.4423.1815.7193.6890.5127.9720.432.797.960.171650.4122.6924.98116.5630.01-1.4848.97
Data as of Jun 07 2024. Currency figures normalised to Sigma Healthcare Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

33.89%Per cent of shares held by top holders
HolderShares% Held
Cooper Investors Pty Ltd.as of 03 May 202495.77m5.87%
Paradice Investment Management Pty Ltd.as of 29 Jan 202471.00m4.35%
The Vanguard Group, Inc.as of 09 May 202456.85m3.48%
Allan Gray Australia Pty Ltd.as of 05 Sep 202254.51m3.34%
Dimensional Fund Advisors LPas of 14 Apr 202354.48m3.34%
Macquarie Bank Ltd. (Private Banking)as of 05 Sep 202254.48m3.34%
First Sentier Investors (Australia) IM Ltd.as of 20 Jun 202354.30m3.33%
Colonial First State Investments Ltd.as of 12 Oct 202252.52m3.22%
First Sentier Investors RQI Pty Ltd.as of 15 Mar 202330.24m1.85%
Wilson Asset Management (International) Pty Ltd.as of 30 Jun 202328.80m1.77%
More ▼
Data from 30 Nov 2019 - 24 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.